FAP and neoplasm: We observed a high blood uptake (5–12 %ID/g at 1 h post-injection) in a mouse model with decreased tumor uptake in comparison to the 68Ga-labeled monospecific counterparts, PSMA-targeted [68Ga]Ga-HTK03041 and FAP-targeted [68Ga]Ga-FAPI-04.